<DOC>
	<DOC>NCT01310985</DOC>
	<brief_summary>A Pilot Trial of Pre-Operative Chemoradiotherapy Using Capecitabine (Xelodaâ), External Beam Radiation and Cetuximab (Erbitux®) Followed by Definitive Surgery in Patients With Localized (Non-Metastatic) Rectal Cancer</brief_summary>
	<brief_title>A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation &amp; Cetuximab, in Rectal Cancer</brief_title>
	<detailed_description>Its a pilot study of pre-op chemotherapy and RT utilizing CAPECITABINE, XRT and CETUXIMAB in pts with locally advanced rectal carcinoma.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Patients with Localized NonMetastatic Rectal Cancer Patients with diagnosis other than Localized NonMetastatic Rectal Cancer</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Rectal Cancer</keyword>
</DOC>